Announcements Trials
Browse Landscape

Phase

Phase 1/2 2Phase 4 1Phase 3 1

Status

Unknown 1Terminated 1Suspended 1Recruiting 1

Sponsor Class

OTHER 23INDUSTRY 4OTHER_GOV 1NIH 1FED 1

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 4NET 1Endocrine 1

Conditions

Carcinoma, Hepatocellular 3Neuroendocrine Tumors 1Hypoxia 1Colorectal Cancer Metastatic 1

Interventions

pembrolizumab 1023Carboplatin 964Paclitaxel 933Gemcitabine 794Cisplatin 751Docetaxel 683Bevacizumab 609Pemetrexed 502Nivolumab 487Cyclophosphamide 471Capecitabine 461Fluorouracil 418Dexamethasone 403Rituximab 372Oxaliplatin 348Injections 345atezolizumab 298Trastuzumab 298Leucovorin 288Cetuximab 282Irinotecan 268130-nm albumin-bound paclitaxel 254Prednisone 245Doxorubicin 240Ipilimumab 226Lenalidomide 220fludarabine 218Fulvestrant 217durvalumab 205Erlotinib Hydrochloride 188

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
INDUSTRY × Interventional × Ethiodized Oil × Clear all
NCT02174549 2026-04-20

Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer

Teclison Ltd.

Phase 1/2 Recruiting
25 enrolled
EndocrineGastrointestinalNET

Hypoxia, Carcinoma, Hepatocellular, Neuroendocrine Tumors

NCT05435014 2026-04-14

T-ACE Oil by TAE/TACE in Patients With Hepatocellular Carcinoma

T-ACE Medical Co., Ltd

Phase 1/2 Suspended
82 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT01387932 2021-11-30

HiQuality

Merit Medical Systems, Inc.

Phase 3 Terminated
235 enrolled 11 charts
Gastrointestinal

Carcinoma, Hepatocellular

NCT01959061 2017-03-13

TACE

Nanjing Chia-tai Tianqing Pharmaceutical

Phase 4 Unknown
320 enrolled
Gastrointestinal

Colorectal Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡